Chr. Hansen’s Chief Executive Officer Cees de Jong has informed the Company that after having led Chr. Hansen as CEO for almost 5 years, he intends to pursue a career as a non-executive director outside Chr. Hansen in due course.
The Company has initiated a process to find his replacement, and until then Cees de Jong will continue as CEO of Chr. Hansen.
Ole Andersen, Chairman of the Company’s Board of Directors, says: “Cees has done a tremendous job for Chr. Hansen and its shareholders, employees and other stakeholders. Together with the Corporate Leadership Team, Cees has steered the Company while delivering in accordance with our financial goals, helped develop an ambitious strategy and been a driving force behind our initiatives to pursue new growth opportunities. Chr. Hansen will be in a much stronger shape when Cees leaves, than when he arrived. We have several new and exciting prospects. I therefore look forward to identifying and appointing a new CEO for Chr. Hansen among the very strong candidates there will naturally be for this attractive position.”
Cees de Jong says: “Chr. Hansen has a unique competence base and strong growth prospects, and it is, and has been, a privilege to be the CEO since 2013. The Company and its employees have been creating excellent results and are continuing to deliver on the “Nature’s No. 1” strategy, turning Chr. Hansen into a true global microbial solutions company. While I am choosing now to pursue a different career, I will continue fully dedicated in my role as CEO for Chr. Hansen until my replacement has been found”.
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable biotech company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.